Preparation and evaluation of chitosan–itraconazole co-precipitated nanosuspension for ocular delivery

References

• Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res. 1998;15:1326–1331.
   PubMed Web of Science ®Google Scholar
• Zerrouk N, Mennini N, Maestrelli F, Chemtobm C, Mura P. Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen. Eur J Pharm Biopharm. 2004;57:93–99.
   PubMed Web of Science ®Google Scholar
• Mutalik S, Anju P, Manoj K, Usha AN. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach. Int J Pharm. 2008;350:279–290.
   PubMedGoogle Scholar
• Park KM, Bae JW, Joung YK, Shin JW, Park KD. Nanoaggregate of thermosensitive chitosan-Pluronic for sustained release of hydrophobic drug. Colloids Surf B Biointerfaces. 2008;63:1–6.
   PubMed Web of Science ®Google Scholar
• Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gurny R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm. 1999;180:185–193.
   PubMed Web of Science ®Google Scholar
• Alonso MJ, Sanchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol. 2003;55:1451–1463.
   PubMed Web of Science ®Google Scholar
• Verreck G, Six K, Van den Mooter G, Baert L, Peeters J, Brewster ME. Characterization of solid dispersions of itraconazole and hydroxypropyl methylcellulose prepared by melt extrusion – part I. Int J Pharm. 2003;251:165–174.
   PubMed Web of Science ®Google Scholar
• Tao T, Zhao Y, Wu J, Zhou B. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement. Int J Pharm. 2009;367:109–114.
   PubMed Web of Science ®Google Scholar
• Hasan HA, Al-Marzouqi AH, Jobe B, Hamza AA, Ramadan GA. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with β-cyclodextrin using supercritical carbon dioxide. J Pharm Biomed Anal. 2007;45:243–250.
   PubMedGoogle Scholar
• Kalavathy CM, Parmar P, Kaliamurthy J, Philip VR, Ramalingam MDK, Jesudasan CAN, Thomas PA. Comparison of topical itraconazole 1% with topical Natamycin 5% for the treatment of filamentous fungal keratitis. Cornea. 2005;24:449–452.
   PubMed Web of Science ®Google Scholar
• Savani DV, Perfect JR, Cobo LM, Durack DT. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother. 1987;31:6–10.
   PubMed Web of Science ®Google Scholar
• Guzek JP, Roosenberg JM, Gano DL, Wessels IF. The effect of vehicle on corneal penetration of triturated ketoconazole and itraconazole. Ophthalmic Surg Lasers. 1998;29:926–929.
   PubMedGoogle Scholar
• Martinez-R M, Claros-B JA, Vale-O MA, Siso-V E, Padilla R, Santiago A, Simon JA. Effect of the vehicle on the topical itraconazole efficacy for treating corneal ulcers caused by Aspergillus fumigates. Clin Experiment Ophthalmol. 2008;36:335–338.
   PubMedGoogle Scholar
• Jafarinejad S, Gilani K, Moazeni E, Ghazi-Khansari M, Najafabadi AR, Mohajel N. Development of chitosan-based nanoparticles for pulmonary delivery of itraconazole as dry powder formulation. Powder Technol. 2012;222:65–70.
   Web of Science ®Google Scholar
• Fessi HC, Devissaguet JP, Puisiex F, Thies C. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent 5, 118, 528. 1992.
   Google Scholar
• Sinswat P, Gao X, Yacaman MJ, Williams RO, Johnston KP. Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution. Int J Pharm. 2005;302:113–124.
   PubMed Web of Science ®Google Scholar
• Sharma R, Ahuja M, Kaur H. Thiolated pectin nanoparticles: preparation, characterization and ex vivo corneal permeation study. Carbohydr Polym. 2012;87:1606–1610.
   Web of Science ®Google Scholar
• Yadav M, Ahuja M. Preparation and evaluation of nanoparticles of gum cordia, an anionic polysaccharide for ophthalmic delivery. Carbohydr Polym. 2010;81:871–877.
   Web of Science ®Google Scholar
• Malhotra M, Majumdar DK. Aqueous, oil and ointment formulations of ketorolac: efficacy against the prostaglandin E2-induced inflammation and safety – a technical note. AAPS Pharm Sci Tech. 2006;7:E99–E104.
   Google Scholar
• Moschwitzer J, Achleitner G, Pomper H, Muller RH. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur J Pharm Biopharm. 2004;58:615–619.
   PubMed Web of Science ®Google Scholar
• Moffat AC, Osselton DM, Widdop B. Clarke's analysis of drugs and poisons. London (UK): Pharmaceutical Press; 2004.
   Google Scholar
• Kovacs K, Stampf G, Klebovich I, Antal I, Ludanyi K. Aqueous solvent system for the solubilization of azole compounds. Eur J Pharm Sci. 2009;36:352–358.
   PubMed Web of Science ®Google Scholar
• Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56:827–840.
   PubMed Web of Science ®Google Scholar
• Mosharraf M, Sebhatu T, Nystrom C. The effects of disordered structure on the solubility and dissolution rates of some hydrophilic, sparingly soluble drugs. Int J Pharm. 1999;177:29–51.
   PubMed Web of Science ®Google Scholar
• Malhotra M, Majumdar DK. Permeation through cornea. Ind J Exp Biol. 2001;39:11–24.
   PubMedGoogle Scholar
• Calvo P, Vila-Jato JL, Alonso MJ. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J Pharm Sci. 1996;85:530–536.
   PubMed Web of Science ®Google Scholar